Business News News 5 November 2025

Archer Aviation (ACHR) Raises $650M, Moves to Buy Hawthorne Airport for $126M; Shares Slip After Q3 Update — Nov. 7, 2025

Archer Aviation Inc. (NYSE: ACHR) unveiled a multi‑pronged update tied to its third‑quarter results: a $650 million equity raise, a deal to acquire control of Los Angeles’ Hawthorne Airport for $126 million, fresh flight‑test milestones for its Midnight eVTOL, and

7 November 2025

Aviation·Business News·Mergers & Acquisitions·Stock Market

Tesla’s ‘Affordable’ EV Gamble Backfires – Stock Sinks as Cheaper Models Disappoint Investors

Tesla Shareholders Approve Elon Musk’s $1 Trillion Pay Plan — What Passed on Nov. 7, 2025, and the 12 Milestones He Must Hit

AUSTIN, Texas — November 7, 2025 (updated) Key points What just happened Tesla shareholders handed Elon Musk a resounding victory, approving a new, decade‑long performance plan with potential value described as up to $1 trillion—a record scale in corporate pay if all hurdles

7 November 2025

Business News·Elon Musk·Stock Market·Tesla

CarMax (KMX) Ousts CEO Bill Nash, Warns of Weak Q3; Shares Slide ~12% — Nov. 6, 2025

CarMax (NYSE: KMX) said its board terminated CEO Bill Nash effective Dec. 1 and named director David McCreight interim CEO. The used‑car giant also issued a downbeat Q3 outlook, sending KMX shares lower on Nov. 6, 2025. CarMax, Inc. announced

6 November 2025

Automotive Industry·Business News·Earnings Reports·Stock Market

McConnell’s Hemp Crackdown Collides With Retail THC Boom: Big Brands, 39 AGs, and Congress Face a ‘Hemp War’ (Nov. 6, 2025)

Why this matters now The seven‑year experiment that legalized hemp (2018 Farm Bill) has morphed into a high‑stakes fight over hemp‑derived intoxicants such as delta‑8, delta‑10, THCA and other cannabinoids. Today, big CPG and alcohol interests publicly pressed Congress to

6 November 2025

Business News

Arm Holdings (ARM) Beats Q2, Lifts Q3 Outlook on AI Momentum — What to Know Today (Nov. 6, 2025)

Why Arm is rallying today Arm delivered another “beat‑and‑raise” quarter as AI workloads continue to shift toward Arm’s power‑efficient compute. Revenue of $1.14B (+34% YoY) topped expectations, while non‑GAAP EPS of $0.39 cleared the Street. Management guided Q3 well above

6 November 2025

Artificial Intelligence·Business News·Earnings Reports·Stock Market·Technology

Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer (PFE) today: Court denies bid to block Novo–Metsera deal; Pfizer preps sweeter offer and leans on higher 2025 EPS outlook

Key takeaways What happened today (Nov. 6) 1) Court clears the way for Metsera to pivot to Novo’s richer bid.On Wednesday evening, the Delaware Chancery Court denied Pfizer’s TRO request that sought to keep Metsera bound to its earlier merger

6 November 2025

Business News·Corporate Strategy·Mergers & Acquisitions·Pharmaceuticals·Stock Market

JELD‑WEN to cut 850 jobs and trims 2025 outlook after deep Q3 loss; Europe business under strategic review

Date: Nov. 6, 2025 Key takeaways What’s new today (Nov. 6) Following Monday’s earnings release, JELD‑WEN confirmed it will shed ~850 positions across North America and corporate functions and is reviewing strategic alternatives for its Europe segment. The workforce actions,

6 November 2025

Business News·Financial Results·Market Outlook

OpenAI’s DevDay Bombshells: No-Code AgentKit, ChatGPT App Store & Jony Ive’s AI Vision

OpenAI News Today (Nov 5, 2025): 1M Business Customers, SoftBank JV in Japan, and Turner’s ‘Wall‑to‑Wall’ ChatGPT Rollout

Published: November 5, 2025 TL;DR OpenAI crosses 1 million business customers OpenAI announced that more than 1 million organizations now pay for its products—either ChatGPT for Work or via its developer platform—calling it “the fastest‑growing business platform in history.” The

5 November 2025

Artificial Intelligence·Business News·Technology

Pfizer Stock Plunge and Promise: Vaccine Slump, Weight-Loss War, and a $10B Gamble – Is PFE Poised for a Comeback?

Company Overview & Stock Snapshot Pfizer Inc. is one of the world’s largest pharmaceutical companies, known for household-name drugs and vaccines. Headquartered in New York, Pfizer manufactures treatments across vaccines, oncology, immunology, cardiology, and more. The company gained global prominence

5 November 2025

Business News·Healthcare Industry·Investing·Pharmaceuticals·Stock Market

China Import Expo 2025 Shatters Records: $40B Deals, US Firms Return After Xi–Trump Summit – Experts Sound Off

Expo Highlights & Speeches The CIIE is China’s flagship trade fair to demonstrate “free trade credentials” and attract imports Reuters Scmp. Premier Li stressed high-level opening-up, promising to keep China’s economy “fairer and more transparent” Reuters. Reuters notes Li said

5 November 2025

Business News·China Economy·Global Markets·International Trade·Investment

McDonald’s Q3 Earnings: Snack Wrap Comeback Drives Sales — Is Stock Primed to Soar?

Robust Sales Amid Value Push McDonald’s third-quarter report topped sales forecasts, thanks largely to customer spending per visit. U.S. sales growth (2.4%) exceeded last year’s 0.3%, as diners took advantage of limited-time deals Newsmax Newsmax. International markets also turned in

5 November 2025

Business News·Earnings·Stock Market

AI & Quantum Frenzy Propels IBM Stock to New Heights – Will the Rally Last?

IBM’s Shock Q4 Layoffs: Thousands of Jobs Cut as Big Blue Doubles Down on AI and Software—What It Means for You and the Stock

Key facts (Nov. 5, 2025) What happened and why now IBM confirmed it is cutting jobs in the fourth quarter of 2025, affecting “thousands” of employees. The company framed the move as a routine workforce rebalance to align headcount with

5 November 2025

Artificial Intelligence·Business News·Stock Market·Technology

Business News News 5 November 2025 - 7 November 2025